Leukoaraiosis in stroke patients hospitalized in stroke unit
Keywords:
cerebral stroke, ischemic stroke, hemorrhagic stroke, cerebrovascular apoplexy, white matter changes, cerebral small vessel diseaseAbstract
Objective: The aim of the study was to assess the prevalence and risk factors for leukoaraiosis, and its correlation with the score of neurological impairment in the acute stroke patients population.
Materials and methods: The analysis included 100 patients with ischemic and hemorrhagic stroke hospitalized in the stroke unit of the MSW Hospital in Rzeszow from 01.10.2011 to 31.12.2011. All the patients had a CT scans, were neurologically examined using the international stroke scale NIHSS. Demographic, environmental and clinical data of each patient were assessed using the author’s spreadsheet. A group of 41 people (25 women and 16 men) with white matter changes - leukoaraiosis (LA) was divided into two subgroups: patients with ischemic and hemorrhagic stroke. The presence of lacunar lesions and comorbidities was assessed in this population. The results were analyzed statistically.
Results: The average age of patients with stroke and leukoaraiosis was 78.4 years of age and was significantly higher than the age of patients with stroke without periventricular white matter changes (72.7 years). Leukoaraiosis was present in 62% of women and 39% of men. Based on chi-square test it was confirmed that being a female is a factor predisposing to white matter changes - LA. Malacic ischemic lesions were more frequent in patients with leukoaraiosis (51.3%) comparing to the group of patients with normal CT scans of white matter (33%). The average and the highest scores of neurological deficit in patients with stroke and LA (respectively 10 and 26) were lower than in patients without white matter changes (scores respectively:12.0 and 37). The most common comorbidities associated with leukoaraiosis were hypertension (87.8%) and hypercholesterolemia (65.8%), which appeared respectively in 6.8% and 23.7% of patients with normal CT of white matter. The prevalence of other diseases like coronary heart disease, diabetes, circulatory insufficiency, dementia, hypothyreosis and hyperthyreosis were more frequent in patients without the pathological changes in white matter.
Conclusions: Gender and age are important leukoaraiosis risk factors. The frequency of LA in the studied population was 41%. Leukoaraiosis predisposes to ischemic stroke with lower neurological deficit. Lacunar ischemic lesions are more frequent in patients with periventricular white matter changes. Hypercholesterolemia and hypertension are the most common comorbidities coexisting with leukoaraiosis.
Downloads
References
Hachiński V, Potter P, Merskey H.Leukoaraiosis. ArchNeurol 1987;44: 21-23.
VianaBaptista M, Bugalho P, Jordo C, Ribeiro O, EsperançaPina J, Ferro J. Motor dysfunction correlates with frontal white matter ischemic changes in patients with leukoaraiosis. J Aging Res2011;95: 341-347.
Srikanth V, Beare R, Blizzard L, Phan T, Stapleton J, Chen J. Cerebral white matter lesions, gait, and the risk of incident falls: a prospective population-based study. Stroke2009;40:175-180.
Roman G, Erkinjuntti T, Wallin A, Pantoni L, Chui H. Subcortical ischaemic vascular dementia. Lancet Neurol2002;1: 426–436.
Opala G, Ochudło S. Obraz kliniczny i różnicowanie otępienia naczyniowego. UdarMózgu 2004;6: 7–16.
Leys D, Englund E, Del Ser T, Inzitari D, Fazekas F, Bornstein N. White matter changes in stroke patients. Relationship with stroke subtype and outcome. EurNeurol 1999;42:67-75.
Van Swieten J, Hijdra A, Koudstaal P i wsp. Grading white matter lesions on CT and MRI: a Simple scale. J NeurolNeurousrg Psychiatry 1990;53: 1080-1083.
Wahlund L, Barkhof F, Fazekas F iwsp. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT. Stroke 2001;32: 1318-1322.
Breteler M, Van Swieten J, Bots Miwsp.Cerebral white matter lesions, vascular risk factors and cognitive function in a population-based study: the Rotterdam study. Neurology1994; 44: 1246–1252.
Longstreth W, Manolio T, Arnold A i wsp.Clinical correlatesof white matter findings on cranial magnetic resonanceimaging of 3301 elderly people. The Cardiovascular HealthStudy. Stroke 1996;27: 1274–1282.
De Leeuw F, De Groot J, Achten Eiwsp. Prevalence ofcerebral white matter lesions in elderly people: a populationbased magnetic resonance imaging study. The Rotterdam ScanStudy. J NeurolNeurosurgPsychiatry 2001;70: 9–14.
Ringelstein E, Nabavi D. Cerebral small vessel diseases: cerebral microangiopathies. CurrOpinNeurol2005;18: 179–188.
Moody D, Bell M, Challa V. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency:an anatomic study. J Neuroradiol1990;11: 431–439.
Taheri S, Gasparovic C, Huisa B, Adair J, Edmonds E, Prestopnik J. Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 2011;42 :2158-2163.
Gons R, De Laat K, Van NordenA,VanOudheusdenL,VanUden I, Norris D. Hypertension and cerebral diffusion tensor imaging in small vessel disease. Stroke 2010;41:2801-2806.
Kim B, Lee S, Kim C, Ryu W, Kwon H, Choi S, Yoon B.Advancedcoronary arterycalcification and cerebral small vessel diseases in the healthy elderly. Circ J 2011;75:451-456.
Ueno Y, Shimada Y, Tanaka R, Miyamoto N, Tanaka Y, Hattori N, Urabe T. Patent foramen ovale with atrial septal aneurysm may contribute to white matter lesions in stroke patients. Cerebrovasc Dis 2010;30:15-22.
De Leeuw F, De Groot J, Oudkerk M iwsp.: Atrial fibrillationand the risk of cerebral white matter lesions. Neurology2000; 54: 1795–1801.
Park K, Yasuda N, Toyonaga S, i wsp. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects.Neurology 2007; 69: 974–978.
Soinne L, Helenius J, Saimanen E i wsp.Brain diffusionchanges in carotid occlusive disease treated with endarterectomy. Neurology 2003;61: 1061–1065.
Kloppenborg R, Nederkoorn P, Van der Graaf Y, Geerlings M. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study. Atherosclerosis2011;216:461-466.
Jochemsen H, Geerlings M, Grool A, Vincken K, Mali W, Van der Graaf Y, Muller M. Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy--the SMART-MR study. J Alzheimers Dis 2012;29:39-49.
Shih C, Chen C, Wen C, Liu H, Kuo H. Relationship between serumuric acid and cerebral white matter lesions in the elderly. NutrMetabCardiovascDis 2012;22:154-159.
Szolnoki Z, Somogyvári F, Kondacs A, Szabó M, Fodor L, Bene J. Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis. ActaNeurolScand 2004;109:222-227.
Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J. A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease.Cerebrovasc Dis 2011;32: 577-588.
De LaatK,VanNorden A, GonsA,VanOudheusdenL,VanUden I. Gait in Eldery With Cerebral Small Vessel Disease. Stroke 2010;41:1652-1658.
Inzitari D, Simon M, Pracucci G, Poggesi A, Basile A, Chabriat H. LADIS Study Group. Risk of rapid global functional decline in eldery patients with severe cerebral age-related white matter changes. Arch Intern Med 2007; 167:81-88.
Palumbo V, Boulanger J, Hill M, Inzitari D, Buchan A. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007;68: 1020-1024.
Smith E, Rosand J, Knudsen B, Hylek E, Greenberg S.Leukoaroiosis is associated with warfin-related hemorrhage following ischemic stroke: the Cardiovascular Helath Study. Neurology 2002;59: 193-197.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
